미국 · 제약
제약
BIOGRAPHENE is a biotech startup dedicated to developing novel graphene-based drugs for neurodegenerative diseases. Our primary targets include Parkinson's disease, Alzheimer's disease, and Niemann-Pick disease type C (NPC). We are a spin-off company from Seoul National University and incorporated as a legal entity in the state of California starting in June 2020.
2017
설립 연도
제약
산업
미국
위치
14,381,110
순위
직원 3명
규모

모든 정보를 보려면 전체 권한을 획득하세요

© Pubrio 2026